Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Search Results (816)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Del Chiaro, MarcoPerson Why?
Schulick, RichardPerson Why?
Messersmith, WellsPerson Why?
NQO1 Inhibitors and Pancreatic Cancer TherapyGrant Why?
Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells.Academic Article Why?
Clinicopathological Characteristics of Young Patients With Pancreatic Cancer: An Analysis of Data From Pancreatic Cancer Registry of Japan Pancreas Society.Academic Article Why?
Neoadjuvant Treatment in Locally Advanced and Borderline Resectable Pancreatic Cancer vs Primary Resectable Pancreatic Cancer.Academic Article Why?
High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment.Academic Article Why?
Landmark Series: Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer.Academic Article Why?
Mechanisms and Drug Targets for Pancreatic Cancer Chemoprevention.Academic Article Why?
Pancreatic cancer treatment: better, but a long way to go.Academic Article Why?
Pancreatic cancer.Academic Article Why?
Pancreatic Exocrine Insufficiency in Pancreatic Cancer.Academic Article Why?
Quality of Life in Patients With Pancreatic Cancer and Their Caregivers: A Systematic Review.Academic Article Why?
Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection?Academic Article Why?
Per Page    Page  of 55last Nextnext
Prev
Search Criteria
  • Pancreatic Cancer
Filter by Type

Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)